InteKrin Therapeutics Appoints Roman Skowronski, MD, PhD as Vice President of Clinical Development

LOS ALTOS‚ Calif., April 23 /PRNewswire-FirstCall/ -- InteKrin Therapeutics Inc., a clinical stage biopharmaceutical company focused on the development of products for diabetes, metabolism and obesity, today announced the appointment of Roman Skowronski, MD, PhD, to the position of Vice Presid

http://digg.com/u1UGbj